Historique
Article de Périodique
Cannabis and mental illness: a review (2019)
Auteur(s) :
LOWE, D. J. E. ;
SASIADEK, J. D. ;
COLES, A. S. ;
GEORGE, T. P.
Année
2019
Page(s) :
107-120
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Anglais
Refs biblio. :
154
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PSY (Psychopathologie / Psychopathology)
Thésaurus mots-clés
CANNABIS
;
PSYCHOPATHOLOGIE
;
SCHIZOPHRENIE
;
PSYCHOSE
;
TROUBLES DE L'HUMEUR
;
ANXIETE
;
TROUBLE DE STRESS POST-TRAUMATIQUE
;
POPULATION A RISQUE
;
FACTEUR DE VULNERABILITE
;
LEGALISATION
;
SANTE MENTALE
;
FACTEUR DE RISQUE
;
DEPRESSION
Résumé :
With the increasing push to legalize cannabis in Western nations, there is a need to gage the potential impact of this policy change on vulnerable populations, such as those with mental illness, including schizophrenia, mood, and anxiety disorders. This is particularly important as there are strong motives in these individuals to seek short-term reward (e.g., "getting high"). Nonetheless, data to support the beneficial effects of cannabis use in psychiatric populations are limited, and potential harms in patients with psychotic and mood disorders have been increasingly documented. This article reviews the effects of cannabis in people with mental illness. Then, we provide a reconciliation of the addiction vulnerability and allostatic hypotheses to explain co-morbidity addiction in mentally ill cannabis users, as well as to further aid in developing a rational framework for the assessment and treatment of problematic cannabis use in these patients.
Affiliation :
Addictions Division, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, USA